Page last updated: 2024-08-21

2-pyrrolidone and piracetam

2-pyrrolidone has been researched along with piracetam in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altomare, C; Carotti, A; Carrupt, PT; Casini, G; Cellamare, S; Ferappi, M; Gaillard, P; Gavuzzo, E; Mazza, F; Testa, B1
Ghelardini, C; Gualtieri, F; Guandalini, L; Martelli, C; Martini, E; Scapecchi, S1
Bialer, M; Finnell, RH; Isoherranen, N; Merriweather, M; Roeder, M; Schurig, V; Spiegelstein, O; Triplett, AA; Yagen, B; Zhang, J1

Other Studies

3 other study(ies) available for 2-pyrrolidone and piracetam

ArticleYear
X-ray crystal structure, partitioning behavior, and molecular modeling study of piracetam-type nootropics: insights into the pharmacophore.
    Journal of medicinal chemistry, 1995, Jan-06, Volume: 38, Issue:1

    Topics: Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Lipids; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Nootropic Agents; Piracetam; Solubility; Stereoisomerism; Structure-Activity Relationship

1995
2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs.
    Farmaco (Societa chimica italiana : 1989), 2003, Volume: 58, Issue:9

    Topics: Animals; Avoidance Learning; Drug Design; Mice; Nootropic Agents; Piracetam; Pyrrolidinones; Structure-Activity Relationship

2003
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity.
    Epilepsia, 2003, Volume: 44, Issue:10

    Topics: Animals; Butyrates; Disease Models, Animal; Female; Fetus; Levetiracetam; Mice; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Pyrrolidines; Pyrrolidinones; Teratogens

2003